References
[1] “Defeating Meningitis by 2030.” https://www.who.int/initiatives/defeating-meningitis-by-2030 (accessed Mar. 16, 2023).
[2] “Twelve year outcomes following bacterial meningitis: further evidence for persisting effects | Archives of Disease in Childhood.” https://adc.bmj.com/content/83/2/111.short (accessed Mar. 21, 2023).
[3] D. Harvey, D. E. Holt, and H. Bedford, “Bacterial meningitis in the newborn: A prospective study of mortality and morbidity,”Seminars in Perinatology , vol. 23, no. 3, pp. 218–225, Jun. 1999, doi: 10.1016/S0146-0005(99)80066-4.
[4] “Meningitis.” https://www.who.int/health-topics/meningitis (accessed Mar. 21, 2023).
[5] P. Nicolas, G. Norheim, E. Garnotel, S. Djibo, and D. A. Caugant, “Molecular Epidemiology of Neisseria meningitidisIsolated in the African Meningitis Belt between 1988 and 2003 Shows Dominance of Sequence Type 5 (ST-5) and ST-11 Complexes,” J Clin Microbiol , vol. 43, no. 10, pp. 5129–5135, Oct. 2005, doi: 10.1128/JCM.43.10.5129-5135.2005.
[6] K. Fernandez et al. , “Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017”.
[7] J. Leimkugel et al. , “Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight- Year Longitudinal Study in Northern Ghana,” PLoS Med , vol. 4, no. 3, p. e101, Mar. 2007, doi: 10.1371/journal.pmed.0040101.
[8] T. Koutangni, H. Boubacar Maïnassara, and J. E. Mueller, “Incidence, Carriage and Case-Carrier Ratios for Meningococcal Meningitis in the African Meningitis Belt: A Systematic Review and Meta-Analysis,” PLoS ONE , vol. 10, no. 2, p. e0116725, Feb. 2015, doi: 10.1371/journal.pone.0116725.
[9] A. Tracy and T. Waterfield, “How to use clinical signs of meningitis,” Arch Dis Child Educ Pract Ed , vol. 105, no. 1, pp. 46–49, Feb. 2020, doi: 10.1136/archdischild-2018-315428.
[10] “Meningitis.” https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON439 (accessed Mar. 16, 2023).
[11] Y. Nishihara, Z. Dangor, N. French, S. Madhi, and R. Heyderman, “Challenges in reducing group B Streptococcus disease in African settings,” Archives of Disease in Childhood , vol. 102, no. 1, pp. 72–77, Jan. 2017, doi: 10.1136/archdischild-2016-311419.
[12] F. Martinón-Torres, “Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements,” Journal of Adolescent Health , vol. 59, no. 2, pp. S12–S20, Aug. 2016, doi: 10.1016/j.jadohealth.2016.03.041.
[13] E. Molyneux et al. , “5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study,” The Lancet , vol. 377, no. 9780, pp. 1837–1845, May 2011, doi: 10.1016/S0140-6736(11)60580-1.
[14] A. M. M. Aye et al. , “Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative,” Journal of Infection , vol. 81, no. 5, pp. 698–711, Nov. 2020, doi: 10.1016/j.jinf.2020.07.025.
[15] X. Bai et al. , “Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe,” Journal of Infection , vol. 79, no. 6, pp. 528–541, Dec. 2019, doi: 10.1016/j.jinf.2019.10.018.
[16] “Preventing and controlling meningitis outbreaks.” https://www.who.int/activities/preventing-and-controlling-meningitis-outbreaks (accessed Mar. 21, 2023).
[17] B. Purcell et al. , “Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review,”BMJ , vol. 328, no. 7452, p. 1339, Jun. 2004.
[18] “The management of acute meningitis: an update | RCP Journals.” https://www.rcpjournals.org/content/clinmedicine/22/5/396 (accessed Mar. 21, 2023).